MATTHEW 25 FUND NVO Holdings History

Number of Shares
41,500.00
Current Holdings Value*
$2.88 Mil
% of Portfolio
1.06%
Total Estimate Gain
$-537,425.00
% of Total Estimate Gain
-15.68%

MATTHEW 25 FUND's Novo Nordisk AS Holding Summary

As of 2025-03-31, MATTHEW 25 FUND held 41,500.00 shares of Novo Nordisk AS(NVO), totaling $2.88 Mil. This investment constitutes 1.06% of their stock portfolio, and MATTHEW 25 FUND now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2025Q1. And since then MATTHEW 25 FUND has made 1 purchases of NVO, at an average price of $82.59, for a total of 41,500.00 shares. Based on historical transaction data and NVO's current price of $69.64, MATTHEW 25 FUND's estimated gain on his NVO holdings is $-537,425.00, reflecting a -15.68% gain to date.

MATTHEW 25 FUND NVO ($69.64) Holding Chart

MATTHEW 25 FUND NVO ($69.64) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1